AK

Amit Kumar

Active Director Director DIN 10259254
DIN 10259254 First appointment Jul 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value •••• Premium profile

About Amit Kumar

Data last updated:

Amit Kumar is a Director at Heartkort Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Heartkort Pharmaceuticals Private Limited reported revenue of ₹7,498 (FY 2024).

DIN 10259254
Primary Designation Director
Industry Pharma
First Appointment 28 Jul 2023
Oldest Company Age 3 yrs
Largest company Heartkort Pharmaceuticals Private Limited · ₹7,498 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Jul 20232023₹7,498 (FY 2024)Active

Board colleagues of Amit Kumar

NameDINCompanyDesignation
Niraj10259253Heartkort Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Heartkort Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Amit Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amit Kumar

Amit Kumar currently holds 1 directorship: Heartkort Pharmaceuticals Private Limited (Director, since 28 Jul 2023, revenue ₹7,498 (FY 2024)).

Amit Kumar was first appointed on 28 Jul 2023 as Director at Heartkort Pharmaceuticals Private Limited.

The current boards of Amit Kumar's companies include Niraj (Heartkort Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available